Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Hoffmann

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Journal of Molecular Biology|November 29, 2007
Novel inhibitor for prolyl tripeptidyl aminopeptidase from Porphyromonas gingivalis and details of substrate-recognition mechanismYue Xu, Yoshitaka Nakajima, Kiyoshi Ito, et al.
Neurobiology of Aging|September 28, 2011
No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's diseaseAntje Hillmann, Stefanie Hahn, Stephan Schilling, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjectsInge Lues, Frank Weber, Antje Meyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Postnatal life events affect the severity of asthmatic airway inflammation in the adult ratCarsten Kruschinski, Thomas Skripuletz, Sammy Bedoui, et al.
Neuropeptides|March 19, 2016
Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulationLeona Wagner, Florian Kaestner, Raik Wolf, et al.
Journal of Neurochemistry|July 17, 2008
Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situStephan Schilling, Thomas Appl, Torsten Hoffmann, et al.
Diabetes Care|July 30, 2002
On combination therapy of diabetes with metformin and dipeptidyl peptidase IV inhibitorsSimon A Hinke, Christopher H S McIntosh, Torsten Hoffmann, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2010
Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligandsJens-Uwe Peters, Torsten Hoffmann, Patrick Schnider, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2005
Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonistsTorsten Hoffmann, Michael Bös, Heinz Stadler, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 28, 2017
Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target OccupancyTorsten Hoffmann, Antje Meyer, Ulrich Heiser, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Journal of Molecular Biology|November 29, 2007
Novel inhibitor for prolyl tripeptidyl aminopeptidase from Porphyromonas gingivalis and details of substrate-recognition mechanismYue Xu, Yoshitaka Nakajima, Kiyoshi Ito, et al.
Neurobiology of Aging|September 28, 2011
No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's diseaseAntje Hillmann, Stefanie Hahn, Stephan Schilling, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjectsInge Lues, Frank Weber, Antje Meyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Postnatal life events affect the severity of asthmatic airway inflammation in the adult ratCarsten Kruschinski, Thomas Skripuletz, Sammy Bedoui, et al.
Neuropeptides|March 19, 2016
Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulationLeona Wagner, Florian Kaestner, Raik Wolf, et al.
Journal of Neurochemistry|July 17, 2008
Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situStephan Schilling, Thomas Appl, Torsten Hoffmann, et al.
Diabetes Care|July 30, 2002
On combination therapy of diabetes with metformin and dipeptidyl peptidase IV inhibitorsSimon A Hinke, Christopher H S McIntosh, Torsten Hoffmann, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2010
Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligandsJens-Uwe Peters, Torsten Hoffmann, Patrick Schnider, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2005
Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonistsTorsten Hoffmann, Michael Bös, Heinz Stadler, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 28, 2017
Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target OccupancyTorsten Hoffmann, Antje Meyer, Ulrich Heiser, et al.
Pageof 8